FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * SAHNI PAYAL 2. Date of Event Requiring Statement (MM/DD/YYYY)
6/29/2020 

3. Issuer Name and Ticker or Trading Symbol PFIZER INC [PFE]
(Last)       (First)       (Middle)
PFIZER INC.-CORP. SECRETARY, 235 EAST 42ND ST.
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Executive Vice President /
(Street)
NEW YORK, NY 10017      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  13393.0000  D   
Common Stock  8662.0000  I  By Rule 16b-3 Plan 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units SSP   (1)  (1) Common Stock  7524.0000   (2) D   
Stock Appreciation Rights  2/25/2021 (3) 2/25/2021 (3) Common Stock  9483.0000  $30.5900  D   
Stock Appreciation Rights  2/25/2023 (4) 2/25/2023 (4) Common Stock  8475.0000  $30.5900  D   
Stock Appreciation Rights  2/23/2022 (3) 2/23/2022 (3) Common Stock  13190.0000  $34.0600  D   
Stock Appreciation Rights  2/23/2024 (4) 2/23/2024 (4) Common Stock  10950.0000  $34.0600  D   
Stock Appreciation Rights  2/27/2025 (3) 2/27/2025 (3) Common Stock  18102.0000  $34.1000  D   
Stock Appreciation Rights  2/27/2027 (4) 2/27/2027 (4) Common Stock  15509.0000  $34.1000  D   
Stock Appreciation Rights  2/22/2023 (3) 2/22/2023 (3) Common Stock  14449.0000  $35.7400  D   
Stock Appreciation Rights  2/22/2025 (4) 2/22/2025 (4) Common Stock  12079.0000  $35.7400  D   
Stock Appreciation Rights  2/28/2024 (3) 2/28/2024 (3) Common Stock  12786.0000  $43.3500  D   
Stock Appreciation Rights  2/28/2026 (4) 2/28/2026 (4) Common Stock  10775.0000  $43.3500  D   

Explanation of Responses:
(1)  These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
(2)  Each unit represents one phantom share of common stock.
(3)  The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
(4)  The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Remarks:
poaps20.htm

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SAHNI PAYAL
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK, NY 10017


Executive Vice President

Signatures
Susan E. Grant, by power of atty., for Payal Sahni 7/9/2020
**Signature of Reporting Person Date
Pfizer (NYSE:PFE)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Pfizer Charts.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Pfizer Charts.